Carrard Justin, Guerini Chiara, Appenzeller-Herzog Christian, Infanger Denis, Königstein Karsten, Streese Lukas, Hinrichs Timo, Hanssen Henner, Gallart-Ayala Hector, Ivanisevic Julijana, Schmidt-Trucksäss Arno
Division of Sports and Exercise Medicine, Department of Sport, Exercise and Health, University of Basel, Basel, Switzerland.
University Medical Library, University of Basel, Basel, Switzerland.
BMJ Open Sport Exerc Med. 2021 Feb 19;7(1):e001008. doi: 10.1136/bmjsem-2020-001008. eCollection 2021.
A low cardiorespiratory fitness (CRF) is a strong and independent predictor of cardiometabolic, cancer and all-cause mortality. To date, the mechanisms linking CRF with reduced mortality remain largely unknown. Metabolomics, which is a powerful metabolic phenotyping technology to unravel molecular mechanisms underlying complex phenotypes, could elucidate how CRF fosters human health.
This study aims at systematically reviewing and meta-analysing the literature on metabolites of any human tissue sample, which are positively or negatively associated with CRF. Studies reporting estimated CRF will not be considered. No restrictions will be placed on the metabolomics technology used to measure metabolites. PubMed, Web of Science and EMBASE will be searched for relevant articles published until the date of the last search. Two authors will independently screen full texts of selected abstracts. References and citing articles of included articles will be screened for additional relevant publications. Data regarding study population, tissue samples, analytical technique, quality control, data processing, metabolites associated to CRF, cardiopulmonary exercise test protocol and exercise exhaustion criteria will be extracted. Methodological quality will be assessed using a modified version of QUADOMICS. Narrative synthesis as well as tabular/charted presentation of the extracted data will be included. If feasible, meta-analyses will be used to investigate the associations between identified metabolites and CRF. Potential sources of heterogeneity will be explored in meta-regressions.
No ethics approval is required. The results will be published in a peer-reviewed journal and as conference presentation.
CRD42020214375.
低心肺适能(CRF)是心脏代谢、癌症和全因死亡率的一个强有力的独立预测指标。迄今为止,将CRF与死亡率降低联系起来的机制在很大程度上仍不清楚。代谢组学是一种强大的代谢表型分析技术,可揭示复杂表型背后的分子机制,它能够阐明CRF如何促进人类健康。
本研究旨在系统回顾和荟萃分析有关任何人体组织样本代谢物的文献,这些代谢物与CRF呈正相关或负相关。报告估计CRF的研究将不被考虑。对用于测量代谢物的代谢组学技术不设限制。将在PubMed、科学网和EMBASE中搜索截至最后一次搜索日期发表的相关文章。两位作者将独立筛选所选摘要的全文。将筛选纳入文章的参考文献和引用文章,以查找其他相关出版物。将提取有关研究人群、组织样本、分析技术、质量控制、数据处理、与CRF相关的代谢物、心肺运动试验方案和运动疲劳标准的数据。将使用QUADOMICS的修改版本评估方法学质量。将包括对提取数据的叙述性综合以及表格/图表展示。如果可行,将使用荟萃分析来研究已鉴定代谢物与CRF之间的关联。将在荟萃回归中探索异质性的潜在来源。
无需伦理批准。研究结果将发表在同行评审期刊上,并在会议上展示。
PROSPERO注册号:CRD42020214375。